GlassScriptPhysician profile
Javier Farinas
NPI 1295227270
$3,337.68
in general payments reported to CMS, 2019-2025
11 companies · $1,509 in 2025
The $1,509 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $169 · 2023: $102 · 2024: $1,558 · 2025: $1,509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,972 · Travel and Lodging: $93.24 · Education: $1.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,971.95 |
| Travel and Lodging | $93.24 |
| Education | $1.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,001.69 | 2024-2025 | Rotapro, Avvigo Guidance System |
| Abiomed | $380.14 | 2024-2025 | Impella |
| Abbott Laboratories | $358.81 | 2024-2025 | Xience Skypoint, Optis, Perclose Prostyle |
| Medtronic, INC. | $343.03 | 2024-2025 | Onyx Frontier, Resolute Onyx |
| Shockwave Medical, INC | $213.95 | 2025 | |
| Asahi Intecc USA, INC. | $175.40 | 2024-2025 | Asahi Coronary Wires, Peripheral Vascular |
| Terumo Medical Corporation | $158.89 | 2024 | Tr Band, Angio-Seal, Optitorque |
| Penumbra, INC. | $141.22 | 2024 | Indigo System |
| Cordis US Corp. | $119.29 | 2024 | Mynx Venous Vcd |
| Inari Medical, INC. | $104.33 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Chiesi USA, INC. | $70.29 | 2024 | Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javier Farinas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.